Novo Nordisk A/S buy BastiBBC
Summary
This prediction ended on 17.04.14 with a price of €31.80. The prediction had a final performance of 27.65%. BastiBBC has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S | - | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by BastiBBC for this prediction
In the thread Novo Nordisk A/S diskutieren
Kaufen
Novo Nordisk kaufen. Durch die Rücksetzer der letzten Monate ist NN günstig zu haben und denoch eine solide Aktie. Ich sehe das Kursziel für die nächsten sechs Monate bei ca. 200 Euro.
Stopped prediction by BastiBBC for Novo Nordisk A/S
Novo Nordisk A/S
06.08.16
06.02.17
06.02.17
Novo Nordisk A/S
17.06.15
17.12.15
17.12.15